Bianca Santos - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Bianca Santos's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Bianca Santos
Verified
Host, CBN Rio
Beats
A , H , Belo Corp , Airlines , Texas Instruments Inc , The Texas And Dallas-fort Worth Economies
financial, business, sports
Content
Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications
By Michael G. Buontempo, Bianca Santos| Wiley Online Library Verified Emerging evidence suggests a potential association between glucagon-like peptide-1 (GLP-1) receptor agonists and alopecia. Drug-induced hair loss is a recognized adverse effect linked to various medications, including chemotherapeutics, immunosuppressants and certain biologics.1 Recently, semaglutide and tirzepatide—two GLP-1 receptor agonists widely used in managing type 2 diabetes mellitus and obesity—have been implicated in hair loss.
By Bianca Santos| Instituto Mauá - 60 anos@ TERçA, 15/10/2024, 11:30 CBN Rio - Entrevista O candidato Carlos Jordy (PL), que está no segundo turno das eleições na cidade de Niterói, participou nesta terça-feira (15) de sabatina no CBN Rio. Ele foi entrevistado pelos âncoras Bianca Santos e Leandro Resende e teve a duração de 10 min e 30 segundos, mesmo tempo de Rodrigo Neves (PDT), sabatinado na segunda-feira (14).
Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications
By Michael G. Buontempo, Bianca Santos| Wiley Online Library Verified Emerging evidence suggests a potential association between glucagon-like peptide-1 (GLP-1) receptor agonists and alopecia. Drug-induced hair loss is a recognized adverse effect linked to various medications, including chemotherapeutics, immunosuppressants and certain biologics.1 Recently, semaglutide and tirzepatide—two GLP-1 receptor agonists widely used in managing type 2 diabetes mellitus and obesity—have been implicated in hair loss.
Company Info
CBN Rio